346 F. Supp. 3d 511
S.D. Ill.2018Background
- Plaintiffs O'Neill and Zamfino bought Hyland's homeopathic teething tablets from Target and CVS and later discarded them after FDA warnings about inconsistent belladonna levels and associated adverse events.
- FDA issued warnings in 2010 and again in 2016–2017 advising consumers to stop using and dispose of certain homeopathic teething tablets and urging recalls; Hyland's/Standard discontinued U.S. distribution and later announced a recall and a consumer refund program.
- Plaintiffs allege defendants made misleading safety representations on product marketing and Hyland's/Standard websites, violating N.Y. Gen. Bus. Law §§ 349 and 350, and that Target/CVS breached implied warranty and contract claims.
- Defendants moved to dismiss for lack of jurisdiction (mootness and standing) and for failure to state claims under Rule 12(b)(6).
- The Court held plaintiffs have Article III standing to pursue damages for purchases they made, but lack standing for injunctive relief because the products are no longer sold; GBL §§ 349/350 claims survived; implied warranty and breach of contract claims against retailers were dismissed.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Mootness of claims due to recall/refund | Recall/refund does not moot claims because plaintiffs haven’t received refunds and statutory damages may exceed refund | Voluntary recall and refund program moot the action | Not moot: plaintiffs' claims survive because refunds are not clearly provided and statutory damages may exceed refunds |
| Article III standing for damages | Plaintiffs suffered economic injury by purchasing products later deemed unsafe and instructed to discard | Plaintiffs failed to plead concrete economic injury | Standing to seek damages sustained (purchase + FDA warnings suffice) |
| Standing for injunctive relief | Seek injunction to prevent future misleading sales | Products are no longer sold; no real or immediate threat of future harm | No standing for injunctive relief; claim dismissed for lack of jurisdiction |
| NY GBL §§ 349/350 claims (material deception/causation) | Website and marketing safety statements were objectively misleading and caused purchases | Plaintiffs didn’t allege they saw statements before purchase or that statements caused injury | GBL claims sufficiently pleaded at motion to dismiss stage; motion denied |
| Implied warranty of merchantability against retailers | Retailers warranted product safety by selling products | Retailers cannot be liable where defect was not discoverable by ordinary inspection of sealed product | Claim dismissed: retailers not plausibly required to have tested sealed product |
| Breach of contract against retailers | Retailers should compensate purchasers for unsafe products | No identified contract terms; no plausible contract pleaded | Claim dismissed for failure to plead contract terms; dismissal with prejudice |
Key Cases Cited
- Lujan v. Defenders of Wildlife, 504 U.S. 555 (standing requires injury in fact, causation, redressability)
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (plausibility standard for pleading)
- Ashcroft v. Iqbal, 556 U.S. 662 (plausibility and pleading standards)
- Stutman v. Chemical Bank, 95 N.Y.2d 24 (elements of N.Y. Gen. Bus. Law § 349 claim)
- Oswego Laborers' Local 214 Pension Fund v. Marine Midland Bank, N.A., 85 N.Y.2d 20 (objective reasonable-consumer standard for deception)
- NECA-IBEW Health & Welfare Fund v. Goldman Sachs & Co., 693 F.3d 145 (permitting some product/claim variation for Article III standing in class context)
- Nicosia v. Amazon.com, Inc., 834 F.3d 220 (no standing for injunctive relief when defendant ceased selling the challenged product)